GSK Investigational Site

Bielefeld, North Rhine-Westphalia 33647

0 studies enrolling now · 8 studies all time

What they study most

Acute Coronary Syndrome, Alzheimer's Disease, Depressive Disorder, Major, Lung Cancer, Non-Small Cell, Pulmonary Disease, Chronic Obstructive, Sepsis

Studies at this site

• GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer — Stopped early
• A Study to Evaluate the Safety of 12 Weeks of Dosing With GW856553 and Its Effects on Inflammatory Markers, Infarct Size, and Cardiac Function in Subjects With Myocardial Infarction Without ST-segment Elevation — Completed
• Clinical Study to Test a New Drug to Treat Major Depression — Completed
• GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults — Completed
• The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial — Completed
• A Phase 3 Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60) — Completed
• Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease — Completed
• Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed